Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



George Simeon Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 George Simeon (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Granted 13,000 options to buy @ $62.59, valued at $813.7k
06/09/2023 4 George Simeon (Director) has filed a Form 4 on Nkarta, Inc.
Txns: Granted 22,500 options to buy @ $4.86, valued at $109.4k
06/02/2023 4 George Simeon (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $5.63, valued at $84.5k
05/15/2023 4 SR ONE CAPITAL MANAGEMENT, LLC (10% Owner) has filed a Form 4 on Arcellx, Inc.
Txns: Sold 631,932 shares @ $45, valued at $28.4M
Sold 370,612 shares @ $45, valued at $16.7M
Sold 6,485 shares @ $46.15, valued at $299.3k
Sold 3,804 shares @ $46.15, valued at $175.6k
12/20/2022 4 George Simeon (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.
Txns: Bought 500,000 shares @ $8.2811, valued at $4.1M
Bought 360,000 shares @ $8.6336, valued at $3.1M
Bought 40,000 shares @ $8.1358, valued at $325.4k
08/17/2022 4 George Simeon (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.
Txns: Disposed/sold 2,253,660 shares @ $76, valued at $171.3M
Disposed/sold 15,000 options to buy @ $27.06, valued at $405.9k
Disposed/sold 8,500 options to buy @ $65.39, valued at $555.8k
Disposed/sold 8,500 options to buy @ $65.64, valued at $557.9k
06/16/2022 4 George Simeon (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $13.69, valued at $205.4k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2022 4 SR ONE CAPITAL MANAGEMENT, LLC (10% Owner) has filed a Form 4 on Arcellx, Inc.
Txns: Converted 1,550,309 shares @ $0
Converted 666,651 shares @ $0
Converted 533,389 shares @ $0
Converted 649,795 shares @ $0
Bought 66,667 shares @ $15, valued at $1M
Converted 433,196 shares @ $0
Bought 1,600,000 shares @ $15, valued at $24M
Converted 1,550,309 preferred shares @ $0
Converted 666,651 preferred shares @ $0
Converted 533,389 preferred shares @ $0
Converted 649,795 preferred shares @ $0
02/03/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
09/02/2021 3 SR ONE CAPITAL MANAGEMENT, LLC (10% Owner) has filed a Form 3 on eFFECTOR Therapeutics, Inc.
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 George Simeon (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.
Txns: Granted 8,500 options to buy @ $65.64, valued at $557.9k
04/01/2021 4 George Simeon (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.
Txns: Converted 4,439,839 shares @ $0
Converted 936,637 shares @ $0
Bought 250,000 shares @ $20, valued at $5M
Converted 7,236,938 preferred shares @ $0
Converted 1,526,718 preferred shares @ $0
03/29/2021 4 George Simeon (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $20, valued at $300k
03/25/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
09/28/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/13/2020 4 George Simeon (Director) has filed a Form 4 on Nkarta, Inc.
Txns: Granted 10,700 options to buy @ $18, valued at $192.6k
07/09/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
06/17/2020 4 George Simeon (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.
Txns: Granted 8,500 options to buy @ $65.39, valued at $555.8k
06/15/2020 4 George Simeon (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Granted 15,000 options to buy @ $59.7, valued at $895.5k
06/08/2020 4 George Simeon (Director) has filed a Form 4 on Principia Biopharma Inc.
Txns: Granted 10,240 options to buy @ $62.66, valued at $641.6k
05/26/2020 4 George Simeon (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.
Txns: Bought 83,333 shares @ $60, valued at $5M
10/22/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/11/2019 4 George Simeon (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.
Txns: Bought 177,777 shares @ $45, valued at $8M
06/13/2019 4 George Simeon (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Granted 15,000 options to buy @ $43.52, valued at $652.8k
06/11/2019 4 George Simeon (10% Owner) has filed a Form 4 on Principia Biopharma Inc.
Txns: Granted 10,240 options to buy @ $31.77, valued at $325.3k
04/24/2019 4 George Simeon (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.
Txns: Converted 1,120,730 shares @ $0
Converted 546,820 shares @ $0
Bought 325,000 shares @ $18, valued at $5.9M
Granted 15,000 options to buy @ $27.06, valued at $405.9k
Converted 4,314,809 preferred shares @ $0
Converted 2,105,259 preferred shares @ $0
04/16/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
01/10/2019 4 George Simeon (10% Owner) has filed a Form 4 on Principia Biopharma Inc.
Txns: Granted 20,475 options to buy @ $17, valued at $348.1k
09/20/2018 4 George Simeon (10% Owner) has filed a Form 4 on Principia Biopharma Inc.
Txns: Converted 1,070,771 shares @ $0
Converted 312,741 shares @ $0
Converted 260,617 shares @ $0
Converted 544,047 shares @ $0
Converted 167,537 shares @ $0
Bought 270,000 shares @ $17, valued at $4.6M
Converted 1,070,771 preferred shares @ $0
Converted 312,741 preferred shares @ $0
Converted 260,617 preferred shares @ $0
Converted 544,047 options to buy @ $0
Converted 167,537 preferred shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy